Susquehanna International Securities’s Novo Nordisk NVO Stock Holding History

Susquehanna International Securities’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,456	Closed	-$358K	–	59
2023 Q4	$358K	Buy	+3,456	New	+$342K	0.26%	40
2023 Q2	–	Sell	-56,044	Closed	-$4.46M	–	46
2023 Q1	$4.46M	Buy	+56,044	New	+$3.97M	2.74%	9
2020 Q4	–	Sell	-40,334	Closed	-$1.39M	–	53
2020 Q3	$1.4M	Sell	40,334 -37,600	-48%	-$1.25M	0.74%	27
2020 Q2	$2.55M	Buy	+77,934	New	+$2.49M	1.06%	26
2020 Q1	–	Sell	-153,000	Closed	-$4.56M	–	102
2019 Q4	$4.43M	Sell	153,000 -27,006	-15%	-$748K	1.68%	17
2019 Q3	$4.65M	Buy	+180,006	New	+$4.55M	1.02%	32
2019 Q2	–	Sell	-29,798	Closed	-$736K	–	93
2019 Q1	$779K	Buy	+29,798	New	+$732K	0.19%	58

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Susquehanna International Securities's NVO Position: Q1 2024 in Review

Susquehanna International Securities sold out of Novo Nordisk (NVO) in Q1 2024, closing a stake of 3,456 shares — an estimated $358K sold.

Susquehanna International Securities first reported a position in NVO in Q1 2019 and held it in 7 quarters. The position peaked at $4.65M in Q3 2019. 1,745 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

Susquehanna International Securities reported no remaining Novo Nordisk position as of Q1 2024 after selling out during the quarter.
Susquehanna International Securities sold 3,456 Novo Nordisk shares in Q1 2024, an estimated $358K.
Susquehanna International Securities first reported a position in Novo Nordisk in Q1 2019 and held it in 7 quarters.
Susquehanna International Securities's Novo Nordisk position peaked at $4.65M in Q3 2019.
1,745 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Susquehanna International Securities's 13F filing for Q1 2024, filed 7 May 2024.